Basaglar Sales Level Off For Lilly

Second-Quarter Sales Stagnant, While First-Half Turnover Is Up By A Tenth

 
• By David Wallace
  
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business